J. Gu

发表

Chronic urticaria in Chinese population: a hospital‐based multicenter epidemiological study

L. He, J. Gu, H. Li, 2014, Allergy.

Efficacy and safety of adalimumab in Chinese patients with moderate‐to‐severe plaque psoriasis: results from a phase 3, randomized, placebo‐controlled, double‐blind study

G. Wang, J. Zheng, M. Okun, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial

Haizhen Yang, Jianzhong Zhang, Qiuning Sun, 2020, The Journal of dermatology.

Laboratory Safety of Dupilumab, and Its Effect on Inflammatory Biomarkers, in Chinese Adults With Moderate-to-Severe Atopic Dermatitis: An Analysis of a Randomized, Double-Blind Phase III Study

N. Dang, Q. Lu, Linfeng Li, 2022, International Journal of Dermatology and Venereology.

The efficacy and safety of dupilumab in Chinese patients with moderate‐to‐severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled study

N. Dang, M. Wang, X. Zhu, 2021, The British journal of dermatology.

A multicentre, randomized, single‐blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once‐daily gel versus clindamycin 1% twice‐daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients

G. Wang, D. Luo, F. Hao, 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

Secukinumab demonstrates high efficacy and a favorable safety profile over 52 weeks in Chinese patients with moderate to severe plaque psoriasis

Q. Guo, Ruo-yu Li, Hao Cheng, 2020, Chinese medical journal.

Prevalence of Acne Inversa (Hidradenitis Suppurativa) in China: A Nationwide Cross-Sectional Epidemiological Study

Hong-Fu Xie, J. Tao, Q. Ju, 2021, International Journal of Dermatology and Venereology.

Diagnosis and Treatment of Acne Inversa/Hidradenitis Suppurativa in China: An Expert Consensus Statement (2021 Version)#

J. Tao, Q. Ju, Xin-feng Wu, 2021, International Journal of Dermatology and Venereology.

Calcipotriol plus betamethasone dipropionate gel compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized, controlled trial investigating efficacy and safety in a Chinese population

T. Gao, Gang Wang, Zhenyi Xu, 2016, International journal of dermatology.

Efficacy and Safety of HLX03, an Adalimumab Biosimilar, in Patients with Moderate-to-Severe Plaque Psoriasis: A Randomized, Double-Blind, Phase III Study

Q. Guo, Xinghua Gao, D. Deng, 2021, Advances in Therapy.

Chinese Experts Consensus on Biologic Therapy for Psoriasis#

H. Gu, Fei Hao, Yuling Shi, 2020 .

Recombinant fusion ESAT6-CFP10 immunogen as a skin test reagent for tuberculosis diagnosis: an open-label, randomized, two-centre phase 2a clinical trial.

X. Fan, S. Lu, Shuihua Lu, 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.

G. Wang, Furen Zhang, Q. Lu, 2022, International immunopharmacology.

Safety of Recombinant Fusion Protein ESAT6-CFP10 as a Skin Test Reagent for Tuberculosis Diagnosis: an Open-Label, Randomized, Single-Center Phase I Clinical Trial

Feng Li, Xiaoyong Fan, Shuihua Lu, 2016, Clinical and Vaccine Immunology.

A randomized, double-blind phase III study to demonstrate the clinical similarity of biosimilar SCT630 to reference adalimumab in Chinese patients with moderate to severe plaque psoriasis.

G. Wang, Furen Zhang, Q. Lu, 2022, International immunopharmacology.

Etanercept biosimilar (recombinant human tumor necrosis factor-α receptor II: IgG Fc fusion protein) and methotrexate combination therapy in Chinese patients with moderate-to-severe plaque psoriasis: a multicentre, randomized, double-blind, placebo-controlled trial

Hong-Fu Xie, Gang Wang, Hong-Zhong Jin, 2019, Archives of Dermatological Research.

Experts Opinion on the Use of Biologic Agents in Psoriatic Patients during COVID-19 Outbreak#

H. Gu, Yuling Shi, Gang Wang, 2020, International Journal of Dermatology and Venereology.